Literature DB >> 17074854

Resistance of primary murine CD4+ T cells to Helicobacter pylori vacuolating cytotoxin.

Holly M Scott Algood1, Victor J Torres, Derya Unutmaz, Timothy L Cover.   

Abstract

Persistent colonization of the human stomach by Helicobacter pylori is a risk factor for the development of gastric cancer and peptic ulcer disease. H. pylori secretes a toxin, VacA, that targets human gastric epithelial cells and T lymphocytes and enhances the ability of H. pylori to colonize the stomach in a mouse model. To examine how VacA contributes to H. pylori colonization of the mouse stomach, we investigated whether murine T lymphocytes were susceptible to VacA activity. VacA inhibited interleukin-2 (IL-2) production by a murine T-cell line (LBRM-33), similar to its effects on a human T-cell line (Jurkat), but did not inhibit IL-2 production by primary murine splenocytes or CD4+ T cells. VacA inhibited activation-induced proliferation of primary human CD4+ T cells but did not inhibit the proliferation of primary murine CD4+ T cells. Flow cytometry studies indicated that the levels of VacA binding to primary murine CD4+ T cells were significantly lower than levels of VacA binding to human CD4+ T cells. This suggests that the resistance of primary murine CD4+ T cells to VacA is attributable, at least in part, to impaired VacA binding to these cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17074854      PMCID: PMC1828377          DOI: 10.1128/IAI.01063-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  Acid activation of Helicobacter pylori vacuolating cytotoxin (VacA) results in toxin internalization by eukaryotic cells.

Authors:  M S McClain; W Schraw; V Ricci; P Boquet; T L Cover
Journal:  Mol Microbiol       Date:  2000-07       Impact factor: 3.501

Review 2.  Helicobacter pylori infection.

Authors:  Sebastian Suerbaum; Pierre Michetti
Journal:  N Engl J Med       Date:  2002-10-10       Impact factor: 91.245

3.  Vacuolating cytotoxin of Helicobacter pylori plays a role during colonization in a mouse model of infection.

Authors:  N R Salama; G Otto; L Tompkins; S Falkow
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

4.  Cutting edge: VacA, a vacuolating cytotoxin of Helicobacter pylori, directly activates mast cells for migration and production of proinflammatory cytokines.

Authors:  Volaluck Supajatura; Hiroko Ushio; Akihiro Wada; Kinnosuke Yahiro; Ko Okumura; Hideoki Ogawa; Toshiya Hirayama; Chisei Ra
Journal:  J Immunol       Date:  2002-03-15       Impact factor: 5.422

5.  A 12-amino-acid segment, present in type s2 but not type s1 Helicobacter pylori VacA proteins, abolishes cytotoxin activity and alters membrane channel formation.

Authors:  M S McClain; P Cao; H Iwamoto; A D Vinion-Dubiel; G Szabo; Z Shao; T L Cover
Journal:  J Bacteriol       Date:  2001-11       Impact factor: 3.490

6.  Helicobacter pylori VacA toxin inhibits human immunodeficiency virus infection of primary human T cells.

Authors:  Kyra Oswald-Richter; Victor J Torres; Mark S Sundrud; Scott E VanCompernolle; Timothy L Cover; Derya Unutmaz
Journal:  J Virol       Date:  2006-09-27       Impact factor: 5.103

7.  A dominant negative mutant of Helicobacter pylori vacuolating toxin (VacA) inhibits VacA-induced cell vacuolation.

Authors:  A D Vinion-Dubiel; M S McClain; D M Czajkowsky; H Iwamoto; D Ye; P Cao; W Schraw; G Szabo; S R Blanke; Z Shao; T L Cover
Journal:  J Biol Chem       Date:  1999-12-31       Impact factor: 5.157

8.  Mice deficient in protein tyrosine phosphatase receptor type Z are resistant to gastric ulcer induction by VacA of Helicobacter pylori.

Authors:  Akihiro Fujikawa; Daisuke Shirasaka; Shoichi Yamamoto; Hiroyoshi Ota; Kinnosuke Yahiro; Masahide Fukada; Takafumi Shintani; Akihiro Wada; Nobuo Aoyama; Toshiya Hirayama; Hiroshi Fukamachi; Masaharu Noda
Journal:  Nat Genet       Date:  2003-02-24       Impact factor: 38.330

9.  Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma.

Authors:  Céu Figueiredo; José Carlos Machado; Paul Pharoah; Raquel Seruca; Sónia Sousa; Ralph Carvalho; Ana Filipa Capelinha; Wim Quint; Carlos Caldas; Leen-Jan van Doorn; Fátima Carneiro; Manuel Sobrinho-Simões
Journal:  J Natl Cancer Inst       Date:  2002-11-20       Impact factor: 13.506

10.  Virulence factors of Helicobacter pylori responsible for gastric diseases in Mongolian gerbil.

Authors:  K Ogura; S Maeda; M Nakao; T Watanabe; M Tada; T Kyutoku; H Yoshida; Y Shiratori; M Omata
Journal:  J Exp Med       Date:  2000-12-04       Impact factor: 14.307

View more
  11 in total

1.  Reconstitution of Helicobacter pylori VacA toxin from purified components.

Authors:  Christian González-Rivera; Kelly A Gangwer; Mark S McClain; Ilyas M Eli; Melissa G Chambers; Melanie D Ohi; D Borden Lacy; Timothy L Cover
Journal:  Biochemistry       Date:  2010-07-13       Impact factor: 3.162

2.  Stimulation of dendritic cells with Helicobacter pylori vacuolating cytotoxin negatively regulates their maturation via the restoration of E2F1.

Authors:  J M Kim; J S Kim; D Y Yoo; S H Ko; N Kim; H Kim; Y-J Kim
Journal:  Clin Exp Immunol       Date:  2011-10       Impact factor: 4.330

Review 3.  Helicobacter pylori: gastric cancer and beyond.

Authors:  D Brent Polk; Richard M Peek
Journal:  Nat Rev Cancer       Date:  2010-06       Impact factor: 60.716

Review 4.  Helicobacter pylori in health and disease.

Authors:  Timothy L Cover; Martin J Blaser
Journal:  Gastroenterology       Date:  2009-05-07       Impact factor: 22.682

5.  Helicobacter pylori VacA enhances prostaglandin E2 production through induction of cyclooxygenase 2 expression via a p38 mitogen-activated protein kinase/activating transcription factor 2 cascade in AZ-521 cells.

Authors:  Junzo Hisatsune; Eiki Yamasaki; Masaaki Nakayama; Daisuke Shirasaka; Hisao Kurazono; Yohtaro Katagata; Hiroyasu Inoue; Jiahuai Han; Jan Sap; Kinnosuke Yahiro; Joel Moss; Toshiya Hirayama
Journal:  Infect Immun       Date:  2007-06-25       Impact factor: 3.441

6.  Helicobacter pylori VacA subdomain required for intracellular toxin activity and assembly of functional oligomeric complexes.

Authors:  Susan E Ivie; Mark S McClain; Victor J Torres; Holly M Scott Algood; D Borden Lacy; Rong Yang; Steven R Blanke; Timothy L Cover
Journal:  Infect Immun       Date:  2008-04-28       Impact factor: 3.441

7.  The intermediate region of Helicobacter pylori VacA is a determinant of toxin potency in a Jurkat T cell assay.

Authors:  Christian González-Rivera; Holly M Scott Algood; Jana N Radin; Mark S McClain; Timothy L Cover
Journal:  Infect Immun       Date:  2012-05-14       Impact factor: 3.441

Review 8.  VacA's Induction of VacA-Containing Vacuoles (VCVs) and Their Immunomodulatory Activities on Human T Cells.

Authors:  Ciara Utsch; Rainer Haas
Journal:  Toxins (Basel)       Date:  2016-06-18       Impact factor: 4.546

Review 9.  Remodeling the host environment: modulation of the gastric epithelium by the Helicobacter pylori vacuolating toxin (VacA).

Authors:  Ik-Jung Kim; Steven R Blanke
Journal:  Front Cell Infect Microbiol       Date:  2012-03-27       Impact factor: 5.293

10.  A role for the vacuolating cytotoxin, VacA, in colonization and Helicobacter pylori-induced metaplasia in the stomach.

Authors:  Jody A Winter; Darren P Letley; Katherine W Cook; Joanne L Rhead; Abed A M Zaitoun; Richard J M Ingram; Karin R Amilon; Nicola J Croxall; Phillip V Kaye; Karen Robinson; John C Atherton
Journal:  J Infect Dis       Date:  2014-03-12       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.